Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Pombo-Suarez M, Sanchez-Piedra C, Garcia-Magallón B, Pérez-Gómez A, Manrique-Arija S, Martín-Doménech R, Colazo M, Campos C, Campos J, Del Pino-Montes J, Arteaga MJ, Cea-Calvo L, Díaz-González F, Gómez-Reino JJ. Pombo-Suarez M, et al. Among authors: del pino montes j. Clin Rheumatol. 2021 Oct;40(10):3979-3988. doi: 10.1007/s10067-021-05742-3. Epub 2021 Apr 27. Clin Rheumatol. 2021. PMID: 33907904
Objectives and methodology of BIOBADASER phase iii.
Sanchez-Piedra C, Hernández Miguel MV, Manero J, Roselló R, Sánchez-Costa JT, Rodríguez-Lozano C, Campos C, Cuende E, Fernández-Lopez JC, Bustabad S, Martín Domenech R, Pérez-Pampín E, Del Pino-Montes J, Millan-Arciniegas AM, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III. Sanchez-Piedra C, et al. Reumatol Clin (Engl Ed). 2019 Jul-Aug;15(4):229-236. doi: 10.1016/j.reuma.2017.08.001. Epub 2017 Sep 19. Reumatol Clin (Engl Ed). 2019. PMID: 28935290 Free article. English, Spanish.
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, Martin-Domenech R, Del Pino-Montes J, Manrique S, Castro-Villegas MC, Ruiz-Montesinos D, Sanchez-Alonso F, Diaz-Gonzalez F, Cea-Calvo L, Gómez-Reino JJ; BIOBADASER Study Group. Hernandez MV, et al. Rheumatol Int. 2019 Mar;39(3):509-515. doi: 10.1007/s00296-018-4177-z. Epub 2018 Oct 24. Rheumatol Int. 2019. PMID: 30353269 Free article.
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.
Gomez-Centeno A, Rubio-Romero E, Ovalles JG, Manrique-Arija S, Marsal-Barril S, Amarelo-Ramos J, Del Pino-Montes J, Muñoz-Fernández S, Bustabad S, Barbazán-Álvarez C. Gomez-Centeno A, et al. Among authors: del pino montes j. Rheumatol Int. 2019 Dec;39(12):2015-2024. doi: 10.1007/s00296-019-04378-6. Epub 2019 Aug 8. Rheumatol Int. 2019. PMID: 31396685
Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis.
Cubino N, Montilla C, Usategui-Martín R, Cieza-Borrela C, Carranco T, Calero-Paniagua I, Quesada A, Cañete JD, Queiro R, Sánchez MD, Hidalgo C, Martínez O, Del Pino-Montes J, Díaz-Álvarez A, González-Sarmiento R. Cubino N, et al. Clin Rheumatol. 2016 Jul;35(7):1789-94. doi: 10.1007/s10067-016-3301-2. Epub 2016 May 17. Clin Rheumatol. 2016. PMID: 27188858
[New therapeutic targets in psoriatic arthritis].
Montilla Morales C, Gómez-Castro S, Sánchez M, López R, Hidalgo C, Del Pino-Montes J. Montilla Morales C, et al. Reumatol Clin. 2012 Mar;8 Suppl 1:S15-9. doi: 10.1016/j.reuma.2012.01.003. Epub 2012 Mar 14. Reumatol Clin. 2012. PMID: 22421457 Free article. Review. Spanish.
100 results